via John Innes Centre
Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases – tuberculosis (TB).
Researchers from the John Innes Centre evaluated two compounds with antibacterial properties, which had been produced by the company Redx Pharma as antibiotic candidates, particularly against TB.
TB, which is caused by the bacterium Mycobacterium tuberculosis, is often thought of as a disease of the past. But in recent years it has been increasing due, in part, to rising resistance to treatments and decreasing efficacy of vaccines.
One strategy in the search for new treatments is to find compounds that exploit well-known existing targets for drugs such as the bacterial enzyme DNA gyrase. This member of the DNA topoisomerase family of enzymes is required for bacterial DNA functionality, so compounds that inhibit its activity are much sought after as antibiotic candidates.
Using X-ray crystallography, the team elucidated the molecular details of the action of the compounds against their target.
Surprisingly, a very common mutation in DNA gyrase that causes bacteria to be resistant to a related group of antibiotics, the aminocoumarins, did not lead to resistance to the compounds under scrutiny here.
“We hope that companies and academic groups working to develop new antibiotics will find this study useful. It opens the way for further synthesis and investigation of compounds that interact with this target,” says Professor Tony Maxwell one of the authors of the study which appears in the Journal of Antimicrobial Chemotherapy.
To date, efforts to develop new treatments for TB have been unsuccessful, with current treatments having been used for over 50 years.
World Health Organisation (WHO) figures reveal that each day over 4,000 people die from TB and 300,000 people fall ill from the disease. Nearly 500,000 people fell ill with drug-resistant TB in 2018.
Professor Maxwell says: “Antimicrobial resistance (AMR) is now well-recognised as one of the biggest problems facing us in the in the 21st Century. If we don’t find solutions to it soon, we could be looking at epidemics of bacterial disease going forward.”
“People know about the bubonic plague and other such terrible pestilence through studying history but it’s not overstating the case that bacterial diseases of this sort could reemerge if we do not have effective antibiotics. We must find a way of bringing together expertise from the academic and business sector towards decisive action.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Tuberculosis
- Enhancing Immunity to Combat Tuberculosis
Researchers explore host-directed therapies, harnessing the body's immune system to combat tuberculosis, including drug-resistant strains.
- The path to a better tuberculosis vaccine runs through Montana
A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any ...
- Experts develop immune-enhancing therapies to target tuberculosis
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the ...
- Revvity unveils a new era of automated tuberculosis testing
Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to ...
- A new hope for tuberculosis?
If we can say “COVID is still here,” then what of tuberculosis (TB), which has been around since time immemorial and has killed more Filipinos than the coronavirus, even during the ...
Go deeper with Google Headlines on:
Tuberculosis
[google_news title=”” keyword=”tuberculosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Antimicrobial resistance
- A vaccine to combat antibiotic resistance
A team of researchers at Michigan State University have outlined an approach to combating a prevalent public health issue: the development of treatment-res | Technology ...
- Cats And Dogs Can Spread Antibiotic Resistant Superbugs To Owners
Transfer of bacteria between sick pets and their humans may be contributing to antibiotic resistance, according to new research.
- COVID-19 Worsened overuse of antibiotics, WHO raises concern over dangers of Antimicrobial Resistance
The use of antibiotics was highly seen among patients with severe or critical COVID-19, with a global average of 81%.
- Experts develop way to harness CRISPR technology to deal with antimicrobial resistance
Antimicrobial resistance (AMR) is continuing to increase globally, with rates of AMR in most pathogens increasing and threatening a future in which every day medical procedures may no longer be ...
- CRISPR is promising to tackle antimicrobial resistance, but bacteria can fight back
In his presentation "How to use CRISPR-Cas to combat AMR" at the ESCMID Global Congress, Assistant Prof. Ibrahim Bitar, Department of Microbiology, Faculty of Medicine and University Hospital in Plzen ...
Go deeper with Google Headlines on:
Antimicrobial resistance
[google_news title=”” keyword=”antimicrobial resistance” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]